Study Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. Citation Text: Roberts R, Rodriguez W, Murphy D, et al. Pediatric Drug Labeling. JAMA. 2003;290(7). doi:10.1001/jama.290.7.905. Copy Citation Format: DOIGoogle ScholarBibTeXEndNote X3 XMLEndNote 7 XMLEndnote taggedPubMedIdRIS Download Citation Save Save to your library Print Share Facebook Twitter Linkedin Copy URL February 9, 2011 Roberts R, Rodriguez W, Murphy D, et al. JAMA. 2003;290(7). View more articles from the same authors. Available at Free full text PubMed citation Save Save to your library Print Share Facebook Twitter Linkedin Copy URL Cite Citation Citation Text: Roberts R, Rodriguez W, Murphy D, et al. Pediatric Drug Labeling. JAMA. 2003;290(7). doi:10.1001/jama.290.7.905. Copy Citation Format: DOIGoogle ScholarBibTeXEndNote X3 XMLEndNote 7 XMLEndnote taggedPubMedIdRIS Download Citation Related Resources From the Same Author(s) Clinical deterioration as a nurse sensitive indicator in the out-of-hospital context: a scoping review. January 24, 2024 Simulation in the executive suite: lessons learned for building patient safety leadership. January 6, 2016 Effects of two commercial electronic prescribing systems on prescribing error rates in hospital in-patients: a before and after study. February 15, 2012 Reducing unacceptable missed doses: pharmacy assistant–supported medicine administration. October 13, 2015 Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2021. November 21, 2021 Preventing diagnostic errors in ambulatory care: an electronic notification tool for incomplete radiology tests. May 13, 2020 Implementation of peer messengers to deliver feedback: an observational study to promote professionalism in nursing. January 18, 2023 A multidisciplinary approach to reduce central line-associated bloodstream infections. March 6, 2013 Reasons provided by prescribers when overriding drug–drug interaction alerts. May 26, 2011 Implementing computerized provider order entry with an existing clinical information system. January 5, 2017 View More Related Resources FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents. July 15, 2020 Medicines in My Home. December 2, 2015 Fentanyl transdermal system (marketed as Duragesic) information. July 10, 2015 FDA Pharmacists Help Consumers Use Medicines Safely. November 19, 2014 Pharmacists' perceptions of computerized prescriber-order-entry systems. October 3, 2011 Prescribing safely for children. July 26, 2011 Nimodipine Capsules (marketed as Nimotop). July 15, 2010 Tamiflu (oseltamivir) for oral suspension: potential medication errors. November 3, 2009 McNeil Consumer & Specialty Pharmaceuticals announces nationwide recall of Children's Tylenol Meltaways - 80 Mg, Children's Tylenol Softchews - 80 Mg and Jr. Tylenol Meltaways - 160 Mg [press release]. June 9, 2009 Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002. July 10, 2008 View More See More About The Topic Physicians Pharmacists Pediatrics Medication Safety
Clinical deterioration as a nurse sensitive indicator in the out-of-hospital context: a scoping review. January 24, 2024
Simulation in the executive suite: lessons learned for building patient safety leadership. January 6, 2016
Effects of two commercial electronic prescribing systems on prescribing error rates in hospital in-patients: a before and after study. February 15, 2012
Reducing unacceptable missed doses: pharmacy assistant–supported medicine administration. October 13, 2015
Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2021. November 21, 2021
Preventing diagnostic errors in ambulatory care: an electronic notification tool for incomplete radiology tests. May 13, 2020
Implementation of peer messengers to deliver feedback: an observational study to promote professionalism in nursing. January 18, 2023
Implementing computerized provider order entry with an existing clinical information system. January 5, 2017
FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents. July 15, 2020
McNeil Consumer & Specialty Pharmaceuticals announces nationwide recall of Children's Tylenol Meltaways - 80 Mg, Children's Tylenol Softchews - 80 Mg and Jr. Tylenol Meltaways - 160 Mg [press release]. June 9, 2009